The Concise Guide to PHARMACOLOGY 2019/20: G protein‐coupled receptors SPH Alexander, A Christopoulos, AP Davenport, E Kelly, A Mathie, ... British journal of pharmacology 176, S21-S141, 2019 | 753 | 2019 |
The Concise Guide to PHARMACOLOGY 2017/18: G protein-coupled receptors. DJA Alexander SPH, Christopoulos A, Davenport AP, Kelly E, Marrion NV ... Br J Pharmacol, S17-S129, 2019 | 655* | 2019 |
Relaxin family peptides and their receptors RAD Bathgate, ML Halls, ET van der Westhuizen, GE Callander, M Kocan, ... Physiological reviews 93 (1), 405-480, 2013 | 544 | 2013 |
The Concise Guide to PHARMACOLOGY 2021/22: G protein‐coupled receptors SPH Alexander, A Christopoulos, AP Davenport, E Kelly, A Mathie, ... British journal of pharmacology 178, S27-S156, 2021 | 461 | 2021 |
Human relaxin gene 3 (H3) and the equivalent mouse relaxin (M3) gene: novel members of the relaxin peptide family RAD Bathgate, CS Samuel, TCD Burazin, S Layfield, AA Claasz, ... Journal of Biological Chemistry 277 (2), 1148-1157, 2002 | 437 | 2002 |
Excitatory amino acid projections to the nucleus accumbens septi in the rat: a retrograde transport study utilizingd [3H] aspartate and [3H] GABA MJ Christie, RJ Summers, JA Stephenson, CJ Cook, PM Beart Neuroscience 22 (2), 425-439, 1987 | 408 | 1987 |
International Union of Pharmacology LVII: recommendations for the nomenclature of receptors for relaxin family peptides RA Bathgate, R Ivell, BM Sanborn, OD Sherwood, RJ Summers Pharmacological reviews 58 (1), 7-31, 2006 | 365 | 2006 |
The concise guide to pharmacology 2017/18: overview SPH Alexander, E Kelly, NV Marrion, JA Peters, E Faccenda, SD Harding, ... British journal of pharmacology 174, S1-S16, 2017 | 310 | 2017 |
The concise guide to PHARMACOLOGY 2015/16: Overview SPH Alexander, E Kelly, N Marrion, JA Peters, HE Benson, E Faccenda, ... British journal of pharmacology 172 (24), 5729-5743, 2015 | 243 | 2015 |
Antidepressant binding sites in brain: autoradiographic comparison of [3H] paroxetine and [3H] imipramine localization and relationship to serotonin transporter. PD Hrdina, B Foy, A Hepner, RJ Summers Journal of Pharmacology and Experimental Therapeutics 252 (1), 410-418, 1990 | 241 | 1990 |
Allosteric ligands of the glucagon-like peptide 1 receptor (GLP-1R) differentially modulate endogenous and exogenous peptide responses in a pathway-selective manner … C Koole, D Wootten, J Simms, C Valant, R Sridhar, OL Woodman, ... Molecular pharmacology 78 (3), 456-465, 2010 | 228 | 2010 |
Relaxin deficiency in mice is associated with an age‐related progression of pulmonary fibrosis CS Samuel, C Zhao, RAD Bathgate, CP Bond, MD Burton, LJ Parry, ... The FASEB Journal 17 (1), 121-123, 2003 | 208 | 2003 |
Cardiovascular effects of relaxin: from basic science to clinical therapy XJ Du, RAD Bathgate, CS Samuel, AM Dart, RJ Summers Nature Reviews Cardiology 7 (1), 48-58, 2010 | 197 | 2010 |
Role of adrenoceptor subtypes in memory consolidation ME Gibbs, RJ Summers Progress in neurobiology 67 (5), 345-391, 2002 | 197 | 2002 |
Ligand‐directed signalling at β‐adrenoceptors BA Evans, M Sato, M Sarwar, DS Hutchinson, RJ Summers British journal of pharmacology 159 (5), 1022-1038, 2010 | 191 | 2010 |
Adrenoceptors and their second messenger systems RJ Summers, LR McMartin Journal of neurochemistry 60 (1), 10-23, 1993 | 175 | 1993 |
The rush to adrenaline: drugs in sport acting on the β‐adrenergic system E Davis, R Loiacono, RJ Summers British journal of pharmacology 154 (3), 584-597, 2008 | 162 | 2008 |
Evolution of β-blockers: from anti-anginal drugs to ligand-directed signalling JG Baker, SJ Hill, RJ Summers Trends in pharmacological sciences 32 (4), 227-234, 2011 | 158 | 2011 |
Relaxin inhibits renal myofibroblast differentiation via RXFP1, the nitric oxide pathway, and Smad2 I Mookerjee, TD Hewitson, ML Halls, RJ Summers, ML Mathai, ... The FASEB journal 23 (4), 1219-1229, 2009 | 158 | 2009 |
Expression of β3‐adrenoceptor mRNA in rat brain RJ Summers, M Papaioannou, S Harris, BA Evans British journal of pharmacology 116 (6), 2547-2548, 1995 | 150 | 1995 |